Chronic L-deprenyl or L-amphetamine: Equal cognitive enhancement, unequal MAO inhibition
References (52)
- et al.
Improvement of cognitive funtion by MAO-B inhibitor L-deprenyl in aged rats
Pharmacol. Biochem. Behav.
(1991) The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl
Mech. Ageing Dev.
(1988)- et al.
Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl
Life Sci.
(1989) - et al.
Maintenance on L-deprenyl prolongs life in aged male rats
Life Sci.
(1990) Spatial localization does not require the presence of local cues
Learn. Motiv.
(1981)- et al.
Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats
Neuropharmacology
(1990) - et al.
Deprenyl alters behavior and caudate dopamine through an amphetamine-like action
Pharmacol. Biochem. Behav.
(1992) - et al.
Brain and monoamine oxidase in aging and in dementia of Alzheimer's type
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1986) - et al.
Ageing, monoamines, and monoamine oxidase levels
Lancet
(1972) - et al.
Subcellular localization of types of A and B monoamine oxidase in rat brain
Biochem. Pharmacol.
(1977)
Formation of a place learning-set by the rat: A new paradigm for neurobehavioral studies
Physiol. Behav.
(1985)
(-) Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
Mod. Probl. Pharmacopsychiatry
(1983)
The potentiation of the anti-akinetic effect after L-dopa treatment by an inhibitor of MAO-B, deprenyl
J. Neural Transm.
(1975)
Tolerance to amphetamines: An examination of possible mechanisms
Selegiline vs. L-acetylcarnitine in the treatment of Alzheimer-type dementia
Clin. Ther.
(1990)
Deprenyl (Selegiline), a selective MAO-B inhibitor with active metabolites: Effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons
J. Pharmacol. Exp. Ther.
(1991)
Selegilline vs. oxiracetam in patients with Alzheimer-type dementia
Clin. Ther.
(1990)
The effect of age on the activity and molecular properties of human brain monoamine oxidase
J. Neural Transm.
(1980)
Experimental and clinical studies of stimulant use in hyperactive children and children with other behavioral disorders
The use of selegiline in Alzheimer's patients with behaviour problems
J. Clin. Psychiatry
(1991)
Deprenyl as symptomatic therapy in Parkinson's disease
Clin. Neuropharmacol.
(1988)
Oxygen free radicals and brain dysfunction
Int. J. Neurosci.
(1991)
Metabolism of (-)deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: A biochemical assessment
Neurology
(1982)
The pharmacology of selegiline ((-)deprenyl). New aspects
Acta Neurol. Scand.
(1989)
Biochemical actions of amphetamine and other stimulants
Metabolism of amphetamine after acute and chronic administration to the rat
J. Pharmacol. Exp. Ther.
(1978)
Cited by (36)
The effects of methamphetamine exposure during preadolescence on male and female rats in the water maze
2007, Behavioural Brain ResearchThe canine model of human cognitive aging and dementia: Pharmacological validity of the model for assessment of human cognitive-enhancing drugs
2005, Progress in Neuro-Psychopharmacology and Biological PsychiatryGenetics of human prefrontal function
2003, Brain Research ReviewsBiochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B
2001, Brain Research Bulletin
- 1
To whom requests for reprints should be addressed.
Copyright © 1993 Published by Elsevier Inc.